Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF – Get Free Report) (TSE:CPH) crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $10.42 and traded as high as $10.69. Cipher Pharmaceuticals shares last traded at $10.63, with a volume of 7,800 shares trading hands.
Cipher Pharmaceuticals Stock Performance
The company’s fifty day moving average is $10.42 and its 200-day moving average is $10.16.
Cipher Pharmaceuticals Company Profile
Cipher Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution indicated for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Ozanex for the topical treatment of impetigo; Vaniqa, a topical cream for the slowing of the growth of unwanted facial hair in women; Durela, an opioid analgesic for the management of moderate to moderately severe pain in adults; Brinavess for the rapid conversion of onset atrial fibriallation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in patients with Acute Coronary Syndrome.
Featured Articles
- Five stocks we like better than Cipher Pharmaceuticals
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Stocks Poised to Benefit From Google’s AI Breakthough
- Golden Cross Stocks: Pattern, Examples and Charts
- Beyond NVIDIA: 5 Semiconductor Stocks Set to Dominate 2026
- What is a Low P/E Ratio and What Does it Tell Investors?
- 3 Stocks You’ll Wish You Bought Before 2026
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
